linkedin post 2021-05-01 05:46:17

IOCB is 50% funded by $90 million/year in royalties from 15 innovative drugs that it has licensed, including : Antivirotics: Duviragel™, cidofovir (Vistide™), adefovir (Hepsera™), tenofovir (Viread™, Truvada™, Atripla™, Striblid™, Complera™); Peptides: Oxytocin™, Adiuretin™, Terlipressin™; Natural Substances: Dermazulen, Lafarex®.” (IOCB = Institute of Organic Chemistry and Biochemistry).

https://lnkd.in/d85eSEg

View in LinkedIn

Share the knowledge
Share the knowledge

SEARCH:

CATEGORIES:

IT MIGHT BE OF YOUR INTEREST: